NCT00279916 - Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions

Otitis Media, SerousNegative Middle Ear PressureRhinitisOtitis Media With EffusionOtitis Media, Secretory

Interventions

DRUG

Triamcinolone acetonide nasal spray

"Subjects aged 12 years or older received 2 metered sprays in each nostril once daily (55 micrograms/spray) (total daily dose 220 micrograms).~Subjects younger than 12 years old received received 1 metered spray in each nostril once daily (55 micrograms/spray) (total daily dose 110 micrograms)."

DRUG

Placebo nasal spray

"Subjects aged 12 years or older received an aqueous solution lacking triamcinolone, 2 metered sprays in each nostril once daily.~Subjects younger than 12 years old received received 1 metered spray of placebo solution in each nostril once daily."

Trial Locations (1)

55905

Mayo Clinic, Rochester